Real life study showing the epidemiological profile and adherence to treatment of patients with severe allergic asthma in use of omalizumab in the past year.

A. Cerci Neto (Londrina, Brazil), O. Ferreira Filho (Londrina, Brazil), F. Chibana (Londrina, Brazil), M. Ribeiro (Londrina, Brazil), R. Kauffmann (Londrina, Brazil), L. Sugehara (Londrina, Brazil), P. Passarelli (Londrina, Brazil), F. Bijetti (Londrina, Brazil)

Source: International Congress 2018 – Biomarkers for evaluating asthma
Session: Biomarkers for evaluating asthma
Session type: Thematic Poster
Number: 1092
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Cerci Neto (Londrina, Brazil), O. Ferreira Filho (Londrina, Brazil), F. Chibana (Londrina, Brazil), M. Ribeiro (Londrina, Brazil), R. Kauffmann (Londrina, Brazil), L. Sugehara (Londrina, Brazil), P. Passarelli (Londrina, Brazil), F. Bijetti (Londrina, Brazil). Real life study showing the epidemiological profile and adherence to treatment of patients with severe allergic asthma in use of omalizumab in the past year.. 1092

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: